Total medical devices industry M&A deals worth $21.21bn were announced in North America in January 2021, led by OptumInsight’s $13bn acquisition of Change Healthcare, according to GlobalData’s deals database.
Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 224.8% over the previous month of $6.53bn and a rise of 304.8% when compared with the last 12-month average of $5.24bn.
North America held a 91.19% share of the global medical devices industry M&A deal value that totalled $23.26bn in January 2021. With a 91.19% share and deals worth $21.21bn, the US was the top country in North America’s M&A deal value across medical devices industry.
In terms of M&A deal activity, North America recorded 26 deals during January 2021, marking a decrease of 23.53% over the previous month and a rise of 18.18% over the 12-month average. The US recorded 25 deals during the month.
North America medical devices industry M&A deals in January 2021: Top deals
The top five medical devices industry M&A deals accounted for 94.3% of the overall value during January 2021.
The combined value of the top five medical devices deals stood at $20.01bn, against the overall value of $21.21bn recorded for the month.
The top five medical devices industry M&A deals of January 2021 tracked by GlobalData were:
1) OptumInsight’s $13bn acquisition of Change Healthcare
2) The $4.6bn acquisition of Cantel Medical by Steris
3) Boston Scientific’s $1.23bn acquisition of Preventice
4) The $635m acquisition of Capsule Technologies by Koninklijke Philips
5) Thermo Fisher Scientific’s acquisition of Mesa Biotech for $550m.